Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04006210 |
Recruitment Status :
Active, not recruiting
First Posted : July 5, 2019
Last Update Posted : November 7, 2023
|
Sponsor:
NeuroDerm Ltd.
Information provided by (Responsible Party):
NeuroDerm Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | November 1, 2022 |
Estimated Study Completion Date : | February 2027 |
Certification/Extension First Submitted : | October 30, 2023 |